中国现代神经疾病杂志 ›› 2026, Vol. 26 ›› Issue (5): 477-481. doi: 10.3969/j.issn.1672-6731.2026.05.004

• 功能神经外科 • 上一篇    下一篇

2 复合程控技术对丘脑底核脑深部电刺激术后帕金森病患者运动功能的疗效分析

柳雯1, 张继波1, 高燕2, 付锴1, 张捷1,*()   

  1. 1. 430071 武汉大学中南医院神经外科功能神经外科诊疗中心
    2. 430071 武汉大学中南医院神经外科功能神经外科体检中心
  • 收稿日期:2026-04-30 出版日期:2026-05-25 发布日期:2026-06-06
  • 通讯作者: 张捷
  • 基金资助:
    国家重点研发计划项目(2016YFC0105900); 国家自然科学基金青年科学基金项目(82501515)

The efficacy of hybrid programming technique on motor function in Parkinson's disease patients with subthalamic nucleus deep brain stimulation

Wen LIU1, Ji-bo ZHANG1, Yan GAO2, Kai FU1, Jie ZHANG1,*()   

  1. 1. Center for Functional Neurosurgery, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China
    2. Health Examination Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China
  • Received:2026-04-30 Online:2026-05-25 Published:2026-06-06
  • Contact: Jie ZHANG
  • Supported by:
    National Key Research and Development Program of China(2016YFC0105900); the National Natural Science Foundation of China for Young Scientists(82501515)

摘要:

目的: 探讨帕金森病患者丘脑底核脑深部电刺激术(STN-DBS)后传统刺激模式下出现症状改善欠佳或难以耐受不良反应时, 采用以交叉电脉冲为核心的复合程控技术的临床疗效。方法: 纳入2018年8月至2024年4月在武汉大学中南医院行STN-DBS的50例帕金森病患者, 术后1个月开机时先采用传统刺激模式, 当传统刺激模式效果欠佳或出现刺激相关不良反应时, 采用以交叉电脉冲为核心的复合程控技术, 分别于术前、术后1个月开机时和术后12个月随访时采用统一帕金森病评价量表第三部分(UPDRS Ⅲ)评估运动功能及记录左旋多巴日等效剂量(LEDD), 并计算术后12个月随访期间传统刺激模式和交叉电脉冲模式比例及其变化特征。结果: 术后1个月开机时, 传统刺激模式占84%(42/50), 随着刺激时间推移, 交叉电脉冲模式比例逐渐增加, 至术后12个月随访时占74%(37/50)。手术前后UPDRS Ⅲ评分(F=333.938, P=0.000)和LEDD(F=187.841, P=0.000)差异有统计学意义, 与术前相比, 术后1个月以传统刺激模式为主时, UPDRS Ⅲ评分(t=17.917, P=0.000)和LEDD(t=14.489, P=0.000)均减少, 术后12个月以交叉电脉冲模式为主时, UPDRS Ⅲ评分(t=18.834, P=0.000)和LEDD(t=13.987, P=0.000)亦减少; 与术后1个月相比, 术后12个月仅UPDRS Ⅲ评分减少(t=8.394, P=0.000)。进一步对手术前后UPDRS Ⅲ分项评分进行比较, 手术前后言语(第18项)、面部表情(第19项)、震颤(第20和21项)和运动功能(第22~31项)评分差异无统计学意义(均P > 0.05)。结论: 帕金森病患者脑深部电刺激术后传统刺激模式下出现症状改善欠佳或难以耐受不良反应时, 采用以交叉电脉冲为核心的复合程控技术可以进一步改善运动症状, 是一种有效的个体化程控策略。

关键词: 帕金森病, 丘脑底核, 深部脑刺激法, 运动障碍, 左旋多巴

Abstract:

Objective: To investigate the clinical efficacy of a hybrid programming technique with interleaving stimulation (ILS) as the main component in Parkinson's disease (PD) patients with subthalamic nucleus deep brain stimulation (STN-DBS) when traditional stimulation (TS) is ineffective or stimulus related side effects occur. Methods: This study retrospectively analyzed the clinical data of 50 primary PD patients who underwent bilateral STN-DBS and were followed up for more than 12 months at Zhongnan Hospital of Wuhan University. The Unified Parkinson's Disease Rating Scale Ⅲ (UPDRS Ⅲ) score and levodopa equivalent daily dose (LEDD) before surgery, at turn-on of the implantable pulse geneator (IPG) one month after surgery, and 12 months after surgery were collected. The proportions of patients receiving ILS due to poor TS effect or stimulus related side effects were calculated and analyzed. Results: About 84% (42/50) of patients used TS at turn-on the IPG one month after surgery, and 74% (37/50) switched to ILS 12 months after surgery. The differences in UPDRS Ⅲ score (F=333.938, P=0.000) and LEDD (F=187.841, P=0.000) were statistically significant before and after surgery. Compared with preoperation, UPDRS Ⅲ score and LEDD significantly decreased at one month after surgery (mainly TS; t=17.917, P=0.000; t=14.489, P=0.000) and 12 months after surgery (mainly ILS; t=18.834, P=0.000; t=13.987, P=0.000). Compared with the turn-on at one month after surgery, the UPDRS Ⅲ score further significantly decreased at 12 months after sugery (t=8.394, P=0.000), but there were no significant improvements in speech, facial expressions, tremors and motor functions subscores (P > 0.05, for all). Conclusions: For PD patients with STN-DBS, when the TS is ineffective or stimulus related side effects occur, the use of hybrid programming with ILS as the core can further improve their motor symptoms. It is an effective personalized programming strategy.

Key words: Parkinson disease, Subthalamic nucleus, Deep brain stimulation, Motor disorders, Levodopa

中图分类号: